11:13 AM EDT, 09/09/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts kicked off the week moving sharply higher late Monday morning, climbing 1.11% to 1,428.14 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm BioNTech (BNTX) and biopharmaceutical company Genfit ( GNFT ) , which rose 5% and 2.5% respectively. They were followed by oil and gas company TotalEnergies (TTE) and financial services company Banco Bilbao Vizcaya Argentaria ( BBVA ) , which were up 1.6% and 1% respectively.

The decliners from continental Europe were led by medical device maker EDAP TMS ( EDAP ) and furniture maker Natuzzi (NTZ), which lost 5.5% and 3.9% respectively. They were followed by biotech firm Evaxion Biotech ( EVAX ) and biopharmaceutical company Calliditas Therapeutics ( CALT ) , which dropped 1.7% and 1.2% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Bicycle Therapeutics ( BCYC ) and biotech firm Autolus Therapeutics ( AUTL ) , which advanced 19.2% and 4% respectively. They were followed by biopharmaceutical companies Adaptimmune Therapeutics ( ADAP ) and Verona Pharma ( VRNA ) , which increased 3.2% and 3% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies TC Biopharm ( TCBP ) and Akari Therapeutics ( AKTX ) , which fell 19% and 5.8% respectively. They were followed by biotech firm Trinity Biotech ( TRIB ) and construction materials supplier CRH (CRH), which were down 3.4% and 2% respectively.